Hyperion DeFi reports 2025 growth across DeFi lines, detailing HYPE treasury volatility and hyperion defi dynamics shaping on-chain yields.Hyperion DeFi reports 2025 growth across DeFi lines, detailing HYPE treasury volatility and hyperion defi dynamics shaping on-chain yields.

Hyperion DeFi delivers triple-dip HYPE deployment and validator growth as hyperion defi ramps diversified DeFi lines in 2025

2026/03/26 19:51
12 min read
For feedback or concerns regarding this content, please contact us at [email protected]
hyperion defi

Hyperion DeFi posted strong Q4 growth in key on-chain operations even as its large HYPE treasury created significant reported volatility for hyperion defi in 2025.

Q4 and full-year 2025 highlights

Hyperion DeFi, Inc. (NASDAQ: HYPD) reported fourth-quarter 2025 GAAP revenue of $496,229, up from $302,506 in Q3 2025, with Non-GAAP Adjusted Gross Profit rising 87% quarter-over-quarter to $820,997 from $439,386. However, sharp HYPE price swings drove a Q4 GAAP net loss of ($39,765,565), versus Q3 net income of $6,625,582.

For full-year 2025, revenue climbed from $57,336 in FY 2024 to $813,455, while net loss narrowed 9% year-over-year to ($45,314,435). Moreover, Net Loss Attributable to Common Stockholders declined to ($46,999,218) from ($49,818,433) in 2024.

CEO Hyunsu Jung said the company is executing a corporate transformation into an institutional gateway for on-chain finance on Hyperliquid, with five DeFi business lines now contributing to financial performance. The company expects these operations to continue scaling through 2026 and beyond.

Guidance and business mix evolution

Hyperion DeFi guided to $4 million–$6 million in Adjusted Gross Profit for FY 2026, implying roughly 4x growth from the $1.28 million recorded in FY 2025. That said, this outlook still depends heavily on token markets and the pace of on-chain activity around HYPE.

By business line, Q4 2025 Adjusted Gross Profit in thousands showed a rapid ramp. Ecosystem Rewards delivered $285 thousand versus zero in Q3; DeFi Monetization surged from less than $1 thousand to $102 thousand; Yield Enhancement edged up to $79 thousand from $78 thousand; Validator Commissions rose to $49 thousand from $21 thousand; and Staking Yield contributed $305 thousand versus $340 thousand. Total Adjusted Gross Profit therefore advanced from $439 thousand to $821 thousand.

Moreover, the company highlighted its evolution beyond a simple digital asset treasury to a diversified DeFi operator on the Hyperliquid blockchain. Management emphasized strong earnings leverage and a low cost base designed for scale, pointing to a 30% quarter-over-quarter decline in Operating Expenses Excluding Stock-Based Compensation, from $4,315,016 in Q3 2025 to $3,007,135 in Q4 2025.

Triple-dip HYPE deployment and staking economics

Hyperion DeFi positions its five DeFi lines to both promote and monetize adoption of Hyperliquid. In Q4 2025, the firm’s so-called “HYPD Triple-Dip” strategy used HYPE tokens across multiple deployments to generate approximately 3x the income the company would have earned from isolated staking.

Under this model, the company stakes its HYPE, redeploys staked HYPE into other activities such as the Joint Validator, Yield Enhancement, or DeFi Monetization, and then positions itself to capture Ecosystem Rewards. This integrated approach underpins its on-chain yield strategy.

Staking Yield remained a core earnings driver. In Q4 2025, Hyperion DeFi earned 8,713 HYPE tokens from staking, up 17% versus 7,437 HYPE in Q3 2025. However, on a dollar basis Adjusted Gross Profit from staking declined 10% quarter-over-quarter, from $340 thousand to $305 thousand, due to the Effective Average HYPE Price In-Period falling from 45.76 to 35.12.

Validator commissions and Yield Enhancement

Validator operations also accelerated. Under its Joint Validator Operators Agreement with Kinetiq and Pier Two, delegated HYPE to the company’s validator increased to 11.8 million tokens as of December 31, 2025, up 43% from 8.2 million as of September 30, 2025. That said, falling HYPE prices tempered dollar-based gains.

Validator Commissions in HYPE jumped to 1,362 tokens in Q4 2025, a 197% increase from 458 tokens in Q3 2025. On a dollar basis, validator commissions generated $49 thousand in Adjusted Gross Profit compared with $21 thousand in Q3, representing 127% quarter-over-quarter growth despite the HYPE price drop.

From December 15, 2025 onward, updates to the Joint Validator structure mean staking yield and validator commissions on third-party delegated HYPE are recognized in GAAP Revenue and Cost of Revenue, but these elements net to zero in Adjusted Gross Profit. This accounting treatment clarifies the separation between treasury economics and operating performance.

Yield Enhancement strategies remained stable contributors. Activities generated $79 thousand in Adjusted Gross Profit in Q4 2025, up marginally from $78 thousand in Q3, a 2% increase. Moreover, Q3 and Q4 activity included selling covered call options on HYPE to institutional counterparties, collateralized by the company’s liquid staking tokens.

In Q1 2026, Hyperion DeFi announced a partnership with Rysk to launch an Institutional Volatility Income Vault, intended to further optimize yield enhancement while building infrastructure to eventually support third-party HYPE deposits into the vault.

DeFi monetization and ecosystem rewards

DeFi Monetization, a key growth vector, generated $102 thousand of Adjusted Gross Profit in Q4 2025 versus less than $1 thousand in Q3 as new strategies began to scale. These initiatives include Temporary HYPE Asset Use Agreements and protocol-level partnerships that leverage the company’s on-chain balance sheet.

Trading volumes on Felix-partner markets cumulatively exceeded $2.8 billion as of March 23, 2026. Moreover, in Q1 2026 the company announced a partnership with the HyperLend protocol to launch a whitelisted lending pool on the HyperEVM network, enabling on-chain borrowing via smart contracts at a rate of 4.0%, well below prior borrowing costs of 8.0%.

Hyperion DeFi also signed a HYPE Asset Use Service Agreement in Q1 2026 with Silhouette AG. The firm agreed to link 100,000 of its owned and staked HYPE tokens to Silhouette’s trading wallet, granting Silhouette and its users reduced trading fees on the Hyperliquid DEX. In return, Hyperion DeFi earns a share of those fee savings plus 100% of associated staking rewards.

Ecosystem Rewards emerged as another meaningful contributor. In Q4 2025, this segment generated $285 thousand of Adjusted Gross Profit, compared with none in Q3. In November 2025, the company received 1,918,478 KNTQ tokens via Kinetiq’s airdrop event, and by March 23, 2026 it had also received 1,000,000 HPL tokens from Hyperlend as part of their on-chain credit pool collaboration.

Given active collaborations with Rysk, Felix, Silhouette, and continued accumulation of Kinetiq points, management expects further ecosystem rewards during 2026. However, the timing and size of such distributions will remain inherently uncertain, as with most airdrop-based revenue streams.

Life sciences pivot and Optejet LOI

While Hyperion DeFi’s focus has shifted decisively to on-chain finance, it still maintains a legacy life sciences project. The Life Sciences segment did not generate any Adjusted Gross Profit in Q3 or Q4 2025, but the company continues to develop its proprietary Optejet User Filled Device (UFD) for ophthalmic applications.

In Q1 2026, the company executed a non-binding Letter of Intent to monetize the Optejet, its final life sciences product. The transaction could close in Q2 2026, marking a further simplification of the business toward pure DeFi infrastructure and treasury-backed yield strategies.

According to management, Optejet is designed for use with various topical eye therapies, including artificial tears and lens rewetting products. Moreover, the device aims to improve front-of-the-eye disease treatment outcomes through ease of use, enhanced safety and tolerability, and potential for better compliance than conventional eye drops.

Non-GAAP metrics and expense discipline

Hyperion DeFi relies on several Non-GAAP indicators to capture operational value creation beyond simple token price moves. Adjusted Gross Profit is intended to reflect all in-period gross profit generated from staking yield, validator operations, yield enhancement, DeFi partnerships, ecosystem rewards, and life sciences activity, while excluding digital asset purchases and mark-to-market shifts.

Other key Non-GAAP measures include Gross HYPE Holdings, Operating Expenses Excluding Stock-Based Compensation, Treasury Gains (Losses), Adjusted Other Income (Expense), Adjusted EBITDA, and Net Asset Value. Moreover, management argues these metrics help isolate core operations from temporary GAAP effects tied to HYPE to liquid staking token conversions and subsequent reconversions.

Operating Expenses Excluding Stock-Based Compensation fell 30% quarter-over-quarter, from $4,315,016 in Q3 2025 to $3,007,135 in Q4 2025. Research and development declined 49% over the same period, from $373,855 to $188,954, while selling, general and administrative expenses excluding stock-based compensation decreased 28%, from roughly $3.9 million to $2.3 million.

At the full-year level, research and development expenses dropped 87%, from $14,462,722 in 2024 to $1,910,430 in 2025, reflecting the strategic pivot away from capital-intensive clinical programs. However, selling, general and administrative costs rose 20% year-over-year to $17,175,698, tracking the build-out of digital asset, trading, and compliance capabilities.

HYPE treasury dynamics and Net Asset Value

Hyperion DeFi’s results remain highly sensitive to the HYPE token. GAAP HYPE digital assets shrank from $37,954,590 as of September 30, 2025 to $16,233,941 as of December 31, 2025, primarily due to price declines. Non-GAAP Gross HYPE Holdings similarly fell from $77,751,604 to $47,837,901 over the same period.

At quarter end, Gross HYPE Tokens totaled 1,881,086, compared with 1,720,549 as of September 30, 2025. The HYPE spot price dropped from $45.19 to $25.43, driving a shift in Treasury Gains (Losses) from $11,868,872 in Q3 2025 to ($36,783,228) in Q4 2025. Net Asset Value decreased from $74,545,583 to $44,154,737 between those dates.

Beyond quarter-end, the HYPE treasury continued to grow in token terms. Gross HYPE Tokens increased from 1.72 million on September 30, 2025 to 1.88 million on December 31, 2025, and exceeded 1.93 million by March 23, 2026. Moreover, the HYPE token price recovered to $38.2 by March 23, 2026, lifting Gross HYPE Holdings to an estimated $73.9 million, while cash, cash equivalents, and USDH rose to approximately $9.2 million.

Profitability, EBITDA and cash flow

On a Non-GAAP basis, Q4 2025 Adjusted EBITDA was ($38,920,649), reversing from $7,951,003 in Q3 2025 because of the adverse treasury mark-to-market impact. Adjusted Other Income (Expense) improved modestly to $48,717 from ($42,240) in Q3.

Q4 2025 Net Loss Attributable to Common Shareholders was ($40.6 million), versus Q3 2025 Net Income Attributable to Participating Securities of $5.8 million. Net loss per share in Q4 was ($6.29) on 6,452,733 weighted average shares outstanding. By comparison, Q3 net income per common share was $0.26 basic on 6,027,713 shares and $0.05 diluted on 28,951,915 shares.

Cash flow trends showed improving operating efficiency. Net Cash Used in Operating Activities fell from $30,120,981 in FY 2024 to $14,770,174 in FY 2025, with $4.1 million of that in Q4 2025. However, Net Cash Used in Investing Activities rose to $71,954,039 in FY 2025, driven primarily by $71,954,039 in purchases of productive digital assets, including $6.3 million in Q4 2025.

Net Cash Provided by Financing Activities increased sharply from $17,554,864 in FY 2024 to $91,046,217 in FY 2025. This reflected $49.4 million of net proceeds from Series A Preferred Stock and warrants in a private placement, $39.4 million in net proceeds from an at-the-market common stock offering (including $9.4 million in Q4 2025), and $4.8 million from warrant exercises, partially offset by $1.5 million of note repayments and $0.9 million of preferred dividends.

Balance sheet position and capital structure

As of December 31, 2025, Hyperion DeFi reported total assets of $51,764,256, up from $3,667,759 a year earlier, primarily due to digital asset holdings. Digital assets stood at $16,345,347, digital assets receivable at $6,935,131, and digital intangible assets at $20,591,555. Current assets totaled $7,245,809, including $6,443,467 in cash and cash equivalents.

Total liabilities were $10,703,749 as of year-end 2025, compared with $16,763,711 at December 31, 2024. Current liabilities dropped to $2,701,013, reflecting the elimination of short-term notes and convertible notes payable that had stood at a combined $9,948,602 a year earlier. Non-current notes payable reached $7,796,136, including a debt discount of $543,230.

Stockholders’ equity turned positive, improving from a deficit of ($13,095,952) at December 31, 2024 to equity of $41,060,507 at December 31, 2025. The company had 5,435,897 shares of Series A Non-Voting Convertible Preferred Stock outstanding, with a liquidation preference of $50,795,000, and 8,680,005 common shares outstanding. Moreover, additional paid-in capital rose to $281,937,072, while accumulated deficit increased to ($240,624,427).

Hyperliquid, HYPE token mechanics and shareholder exposure

The Hyperliquid blockchain underpins Hyperion DeFi’s strategy. It is a next-generation layer 1 optimized for high-frequency trading, with fully on-chain order books for perpetual futures and spot pairs and a reported block time of roughly 70 milliseconds. The chain also hosts the HyperEVM, a general-purpose smart contract platform similar to Ethereum’s virtual machine.

HYPE acts as the native token of Hyperliquid. Staking HYPE provides reduced trading fees and enhanced referral bonuses for users. As of March 2026, more than 41 million HYPE had been autonomously purchased and sequestered by the blockchain using trading fees generated on the network’s central limit order books.

Shareholders in Hyperion DeFi gain compounding exposure to HYPE through both native staking yield and incremental revenues derived from token utility in DeFi partnerships. However, this also means the company’s reported earnings, Net Asset Value, and Non-GAAP treasury metrics remain tightly correlated with the HYPE token’s market price and on-chain activity levels.

Investor communications and outlook

Hyperion DeFi scheduled a conference call for March 26, 2026 at 8:00 a.m. Eastern Time to review Q4 and full-year 2025 results. A slide presentation with supplemental financial data and reconciliations of Non-GAAP to GAAP metrics is available via the company’s Investor Relations website, and the webcast archive will remain online through April 6, 2026 at 11:59 p.m. Eastern Time.

Investors can submit questions in advance by emailing [email protected]. The company’s Investor Contact is Jason Assad, who can also be reached by phone at (678) 570-6791. Moreover, Hyperion DeFi maintains an active presence on X via @hyperiondefi and provides corporate information at Hyperiondefi.com.

In summary, Hyperion DeFi exited 2025 with rapidly expanding DeFi operations, a growing HYPE token base, and tighter expense discipline, but its earnings profile remains heavily influenced by volatile digital asset markets and the trajectory of Hyperliquid ecosystem growth.

Market Opportunity
DeFi Logo
DeFi Price(DEFI)
$0.000356
$0.000356$0.000356
-1.38%
USD
DeFi (DEFI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.